Pre-Clinical work

see ongoing NH125 Plasmodium Inhibitor - next steps pre-clinics

How to progress efficiently through pre-clinics - towards a company

• we need more than one lead compound (best >5). > do an additional, larger screening.
• we need a structure of PfSnf2L with the inhibitor
• we need med-chem
• we need a mouse model
• Optional: Malaria on a chip - disease model